Want to join the conversation?
$DGX's 3Q15 reported operating income was $631MM, or 33.6% of revenues which benefited from the pre-tax gain of $334MM on the contribution to the clinical trials joint venture. In Oct., new companion diagnostic solutions were separately announced for two recent FDA approved therapies for non-small cell lung cancer.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!